NAT10 and esophageal squamous cell carcinoma: NAT10 was found to prolong the mRNA half-life of NOTCH3; consequently, Khib-modified NAT10 increased the mRNA stability of NOTCH3 in an N4-acetylcytidine (ac4C)-modification dependent manner, thus driving ESCC metastasis [154].